EpilepsyNCT06668519
Magnetoencephalography in Children
An observational study of Epilepsy and Intracranial Tumors, run by Children's Hospital of Fudan University at 1 site in China.
Trial summary
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism… Read more about this study
- Who is it for?
- Ages 1 month to 18 years
- Conditions the study is for
- Epilepsy, Intracranial Tumors, Cerebrovascular Disease
- What is being tested?
- Magnetoencephalography
- How many people
- 1,500 participants
- Where
- 1 siteChina
- Study dates
- 25 Sep 2024to 30 Dec 2027
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Children aged 1 month to 18 years old
Who may be able to join
- aged 1 month-18 years old (date of investigate minus date of birth)
- epilepsy
- intracranial tumors
- cerebrovascular diseases
- autism
- mental retardation
Show all 9Show fewer
- ADHD
- tic disorder
- neuropsychiatric disorders
Who cannot join
- 1.Unable to cooperate with the exam of MEG
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Children's Hospital of Fudan University
Shanghai, 201102
yuanfeng Zhou, 18916152087, yuanfengzhou@fudan.edu.cn
About this study
Official title: An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Read the detailed description
The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders
- Conditions
- Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism, ADHD - Attention Deficit Disorder With Hyperactivity, Neuropsychiatric Disorders
- Being tested
- Magnetoencephalography
- Keywords
- neurodevelopmental diseases, magnetoencephalography, pediatric
- Medical subject headings
- Epilepsy, Brain Neoplasms, Cerebrovascular Disorders, Autistic Disorder, Attention Deficit Disorder with Hyperactivity, Tic Disorders, Intellectual Disability, Developmental Disabilities
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MagnetoencephalographyOther
Magnetoencephalography
| Study group | Role | What they receive |
|---|---|---|
| children with neurodevelopmental diseases | Not described Receives: Other: Magnetoencephalography | |
| healthy children | Not described Receives: Other: Magnetoencephalography |
What is being measured
The primary outcome is the main question the study is designed to answer.
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children
Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2024
- Study start25 Sep 2024
- Primary completion30 Dec 2027 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EpilepsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,500 participants (estimated)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Children's Hospital of Fudan University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06668519
- Sponsor's protocol ID
- 2024-173
- Status last verified
- Mar 2026
- First submitted
- 30 Oct 2024
- Last updated
- 25 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders
- ClinicalTrials.gov ID
- NCT06668519
- Acronym / sponsor ID
- 2024-173
- Conditions
- Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism, ADHD - Attention Deficit Disorder With Hyperactivity, Neuropsychiatric Disorders
- Keywords
- neurodevelopmental diseases, magnetoencephalography, pediatric
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 1,500 participants (estimated)
- Lead sponsor
- Children's Hospital of Fudan UniversityUniversity, hospital or other
- Study start
- 25 Sep 2024 (actual)
- Primary completion
- 30 Dec 2027 (estimated)
- Study completion
- 30 Dec 2027 (estimated)
- First posted
- 31 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Detailed description
The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 3 Years
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| children with neurodevelopmental diseases | – | Other: Magnetoencephalography |
| healthy children | – | Other: Magnetoencephalography |
Who may qualify
- Ages
- 1 month to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Children aged 1 month to 18 years old
Key inclusion criteria (9 listed)
- aged 1 month-18 years old (date of investigate minus date of birth)
- epilepsy
- intracranial tumors
- cerebrovascular diseases
- autism
Key exclusion criteria (1 listed)
- 1.Unable to cooperate with the exam of MEG
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MagnetoencephalographyMagnetoencephalography | Other | children with neurodevelopmental diseases, healthy children |
Primary outcome
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children
Time frame: 3 years
Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Epilepsy
Active, not recruitingPhase 3
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Dravet Syndrome
RecruitingObservational study
Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
Epilepsy
Enrolling by invitationPhase 2
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Not yet recruiting
Biomarker Targeted Stimulation for Epileptiform Events
Epilepsy
Enrolling by invitationObservational study
Study of Direct Brain Recording and Stimulation for Memory Enhancement
Epilepsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Epilepsy and Intracranial Tumors, run by Children's Hospital of Fudan University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yuanfeng Zhou (18916152087, yuanfengzhou@fudan.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children (time frame: 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2026.